Cargando…
CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder
Gallbladder cancer is the most common biliary tract malignancy with the worst overall prognosis. CD109 is a co-receptor of TGF-β1 and suppresses TGF-β signaling. In this study, CD109 protein expression in three subtypes of gallbladder cancer was examined by immunohistochemistry on human tissue sampl...
Autores principales: | Dong, Fengyun, Lu, Chuanfeng, Chen, Xiaocui, Guo, Yuan, Liu, Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545819/ https://www.ncbi.nlm.nih.gov/pubmed/26249215 http://dx.doi.org/10.1186/s13000-015-0375-0 |
Ejemplares similares
-
CD109 expression is upregulated in penile squamous cell carcinoma
por: Dong, Fengyun, et al.
Publicado: (2017) -
CD109 and squamous cell carcinoma
por: Qi, Ruixia, et al.
Publicado: (2018) -
TSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder
por: LIU, ZIRU, et al.
Publicado: (2014) -
MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder
por: Liu, Ziru, et al.
Publicado: (2016) -
Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma
por: Zou, Qiong, et al.
Publicado: (2013)